Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis
Pediatric Cardiology · 2024
DOI: 10.1007/s00246-024-03465-1 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pediatric Cardiology, 2024. Verfasst von Monique R Radman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Critical Care, Department of Pediatrics, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, RC.2.820,…. Hauptthemen laut MEDLINE: Triiodothyronine, Cardiopulmonary Bypass. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Specific pediatric populations have exhibited disparate responses to triiodothyronine (T3) repletion during and after cardiopulmonary bypass (CPB). Objective: To determine if T3 supplementation improves outcomes in children undergoing CPB. We searched randomized controlled trials (RCT) evaluating T3 supplementation in children aged 0-3 years undergoing CPB between 1/1/2000 and 1/31/2022. We calculated Hazard ratios (HR) for time to extubation (TTE), ICU length of stay (LOS), and hospital LOS. 5 RCTs met inclusion criteria with available patient-level data. Two were performed in United States (US) and 3 in Indonesia with 767 total subjects (range 29- 220). Median (IQR) age 4.1 (1.6, 8.0) months; female 43%; RACHS-1 scores: 1-1%; 2-55%; 3-27%; 4-13%; 5-0.1%; 6-3.9%; 54% of subjects in US vs 46% in Indonesia. Baseline TSH and T3 were lower in Indonesia (p < 0.001). No significant difference occurred in TTE between treatment groups overall [HR 1.09 (CI, 0.94-1.26)]. TTE numerically favored T3-treated patients aged 1-5 months [HR 1.24 (CI, 0.97-1.60)]. TTE HR for the Indonesian T3 group was 1.31 (CI, 1.04-1.65) vs. 0.95 (CI, 0.78-1.15) in US. The ICU LOS HR for the Indonesian T3 group was 1.19 vs. 0.89 in US (p = 0.046). There was a significant T3 effect on hospital LOS [HR 1.30 (CI, 1.01-1.67)] in Indonesia but not in US [HR 0.99 (CI, 0.78-1.23)]. T3 supplementation in children undergoing CPB is simple, inexpensive, and safe, showing benefit in resource-limited settings. Differences in effects between settings likely relate to depression in baseline thyroid function often associated with malnutrition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiac Critical Care, Department of Pediatrics, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, RC.2.820, Seattle, WA, 98105, USA. monique.radman@seattlechildrens.org.
- New Arch Consulting, Issaquah, WA, USA.
- Division of Pediatric Cardiac Intensive Care, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
- Division of Cardiology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Zitieren
APA
Radman, M. R., Slee, A. E., Marwali, E. M., & Portman, M. A. (2024). Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03465-1
Vancouver
Radman MR, Slee AE, Marwali EM, Portman MA. Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis. Pediatric Cardiology. 2024. doi:10.1007/s00246-024-03465-1
BibTeX
@article{Radman2024,
author = {Radman, Monique R and Slee, April E and Marwali, Eva M and Portman, Michael A},
title = {Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis},
journal = {Pediatric Cardiology},
year = {2024},
doi = {10.1007/s00246-024-03465-1}
}
EUVIMED